These data prompt us to speculate that calcitriol (an active form of vitamin D) has modulatory action on the inappropriate activation of the hepatic RAS under insulin-resistant conditions, and that potential vitamin D supplementation might provide a cost-effective measure for improving hepatic metabolic dysfunction in T2DM and related NAFLD. Here, INS is linked to type 2 diabetes mellitus.